| Accession Number | 0001822499-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Dec 31, 2025 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF SCIENTIFIC OFFICER | Common Stock | โ | Nov 18, 2025 | Grant/Award | 1,000 | $2.31 | $2,310.00 | 17,890 | Direct | โ | View Details | |
CHIEF SCIENTIFIC OFFICER | Common Stock | โ | Dec 31, 2025 | Exercise/Conversion | 3,667 | $0.00 | $0.00 | 21,557 | Direct | โ | View Details | |
CHIEF SCIENTIFIC OFFICER | Common Stock | โ | Jan 2, 2026 | Sale | 876 | $6.88 | $6,026.88 | 20,681 | Direct | โ | View Details | |
CHIEF SCIENTIFIC OFFICER | Restricted Stock Units | Derivative | Dec 31, 2025 | Exercise/Conversion | 3,667 | $0.00 | $0.00 | 0 | Direct | โ | View Details |